| abstract |
VEGF xxx b, used to treat or prevent neuropathy and neurodegenerative disorders, or as a neuroprotective or neuroregenerative agent in vivo or in vitro, VEGF in the recipient's cells or in vitro A substance that selectively promotes the expression of VEGF xxx b in preference to xxx , an expression vector system that causes the expression of VEGF xxx b in a host organism is provided. VEGF xxx b is preferably VEGF 165 b. |